EUVIMEDEUVIMED entdecken
Crossref

Management of Overactive Bladder After Radical Prostatectomy: Safety and Clinical Pathways Following Intradetrusor OnabotulinumtoxinA

Randy G Tsai iD, Lauren P K Muramoto iD, Victor W Nitti

Neurourology and Urodynamics · 02.11.2026

DOI: 10.1002/nau.70519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurourology and Urodynamics, online erschienen am 02.11.2026. Verfasst von Randy G Tsai und 2 weiteren Autor:innen. Beteiligte Einrichtung: David Geffen School of Medicine at UCLA, Los Angeles, California, USA. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Men with overactive bladder (OAB) following radical prostatectomy may undergo intradetrusor onabotulinumtoxinA (onabotA), including in the setting of artificial urinary sphincter (AUS) or male sling placement. However, data regarding urinary retention and de novo clean intermittent catheterization (CIC), as well as longitudinal treatment patterns, remain limited in this population. We evaluated the safety and treatment patterns of onabotA in men with OAB following radical prostatectomy, with particular attention to patients undergoing continence surgery.

Methods

We performed a retrospective single‐center cohort study of adult men with a history of radical prostatectomy undergoing intradetrusor onabotA between 2018 and 2025. Patients were categorized as: (1) onabotA only after radical prostatectomy or (2) an AUS/sling group comprising patients who underwent continence surgery before or during onabotA treatment. The primary outcome was de novo CIC following treatment. Secondary outcomes included elevated postvoid residual (PVR), treatment characteristics, dose escalation, treatment persistence, and descriptive analyses of clinical pathways and urodynamic findings among patients undergoing prior continence surgery. Kaplan‐Meier methods were used to evaluate treatment persistence among patients receiving at least two injections.

Results

Thirty‐two men underwent intradetrusor onabotA after radical prostatectomy. Fourteen comprised the onabotA‐only group and 18 the AUS/sling group, including 17 who underwent continence surgery before onabotA and one who underwent male sling placement after treatment with onabotA. Median follow‐up after first onabotA injection was 1.75 years (IQR 0.57–2.91). Twenty‐two patients (68.8%) received at least two injections, including 50.0% (7/14) and 83.3% (15/18) in the respective groups ( p = 0.062). No patient developed de novo CIC following treatment. Elevated PVR (≥ 200 mL) occurred in 9.4% (3/32) of patients, all in the onabotA‐only group. Among patients receiving repeat treatment, dose escalation to 200–300 units occurred in 50.0% (11/22). Treatment persistence did not differ between groups (log‐rank p = 0.851).

Conclusion

Intradetrusor onabotA demonstrated a favorable safety profile among men with OAB following radical prostatectomy, including those undergoing AUS or male sling placement, with no patients requiring de novo CIC. These findings support consideration of onabotA in appropriately selected patients as part of the individualized management of persistent bladder dysfunction after prostate cancer treatment.

Schlagwörter

Stichwörter der Autor:innen

artificial urinary sphincterclean intermittent catheterizationdose escalationmale slingneurogenic detrusor overactivityonabotulinumtoxinAoveractive bladderpost‐void residualstress urinary incontinence

Autor:innen und Institutionen

  • David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Departments of Urology and Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, UCLA Health, Los Angeles, California, USA.

ORCID-Profile: Randy G Tsai, Lauren P K Muramoto

Zitieren

APA

Tsai, R. G., Muramoto, L. P. K., & Nitti, V. W. (2026). Management of Overactive Bladder After Radical Prostatectomy: Safety and Clinical Pathways Following Intradetrusor OnabotulinumtoxinA. Neurourology and Urodynamics. https://doi.org/10.1002/nau.70519

Vancouver

Tsai RG, Muramoto LPK, Nitti VW. Management of Overactive Bladder After Radical Prostatectomy: Safety and Clinical Pathways Following Intradetrusor OnabotulinumtoxinA. Neurourology and Urodynamics. 2026. doi:10.1002/nau.70519

BibTeX
@article{Tsai2026,
  author = {Tsai, Randy G and Muramoto, Lauren P K and Nitti, Victor W},
  title = {Management of Overactive Bladder After Radical Prostatectomy: Safety and Clinical Pathways Following Intradetrusor OnabotulinumtoxinA},
  journal = {Neurourology and Urodynamics},
  year = {2026},
  doi = {10.1002/nau.70519}
}
Kostenlos starten →